Abstract

BackgroundTwenty-five to 30 million Americans live with a rare disease (RD) and share challenges unique to RD. The majority of research on RDs has focused on etiology, treatment and care, while the limited health-related quality of life (HRQL) research has been restricted to single RDs, small samples, or non-validated measures. This study reports HRQL among adults with diverse RDs, and compares their scores to those of the U.S. population and people with common chronic health conditions.MethodsWe conducted a cross-sectional survey of adults living in the U.S. diagnosed with any RD. Participants were recruited through RD organizations and completed the online survey between December 2016 and May 2017 (n = 1218). HRQL was assessed using the standardized Patient-Reported Outcomes Measurement Information System (PROMIS). RDs were classified into categories defined by Orphanet. Means and 95% confidence intervals were calculated for the main sample and for RD categories and were compared to published U.S. population norms and common chronic disease norms. Intercorrelations were conducted between HRQL, demographics, and RD experiences.ResultsWhen compared to the norms for the U.S. population and for those with common chronic diseases, mean HRQL scores were significantly poorer across all six PROMIS domains for the main sample, and were usually poorer when analyzed by sub-sets of specific RD classifications. People with rare systemic and rheumatologic, neurological, and immune diseases had the poorest HRQL. Participants had poorer HRQL if they had multiple RDs, lower income, were female, or older. Having symptoms longer was associated with worse HRQL, however, having a formal diagnosis longer was associated with better HRQL.ConclusionsThis study is the first to examine HRQL in a large, heterogeneous sample of RDs using validated measures. There is a significant disparity in HRQL among people with RD compared to the general population and people with common chronic diseases. Poor HRQL could be attributed to challenges accessing diagnoses, medical information, treatment, psychosocial support, and coping with stigma and uncertainty. As most individuals with RDs will not be cured in their lifetimes, identifying ways to improve HRQL is crucial to patient-centered care and should be a funding priority.

Highlights

  • Twenty-five to 30 million Americans live with a rare disease (RD) and share challenges unique to RD

  • Researchers confirmed self-reported RDs were rare according to the National Institutes of Health (NIH) definition using their Genetic and Rare Disorder Information Center database [26]

  • It is well documented that individuals with common chronic diseases experience challenges to health-related quality of life (HRQL) [6], our findings show that, as predicted, the experience of living with RD leads to even greater HRQL threat

Read more

Summary

Introduction

Twenty-five to 30 million Americans live with a rare disease (RD) and share challenges unique to RD. There are about 7000 different RD [1], people with diverse RDs share similar challenges [2,3,4]. People quest for doctors with expertise and Bogart and Irvin Orphanet Journal of Rare Diseases (2017) 12:177 information they can trust [3, 4, 8, 11]. For this reason, they turn to RD organizations as their primary source of information and support [4]. Social and environmental barriers like stigma limit ability to participate in social roles and activities [13]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call